Gene · 57721
Papers4,298
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
441 to 460 of 4,298
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Comprehensive Analysis of Crucial m6A-Related Differentially Expressed Genes in Psoriasis. | Front Biosci (Landmark Ed) | 2024 | 39344312 | PubTator, text mining | PubMed |
| N6-Methyladenosine Positively Regulates Coxsackievirus B3 Replication. | Viruses | 2024 | 39339923 | PubTator, text mining | PubMed |
| DNA 5mC and RNA m6A Collaborate to Upregulate Phosphoenolpyruvate Carboxykinase 2 for Kupffer Cell Activation. | Int J Mol Sci | 2024 | 39337381 | PubTator, text mining | PubMed |
| METTL14 depletion induces trophoblast cell dysfunction by inhibiting miR-21-5p processing in an m6A-dependent manner. | Int Immunopharmacol | 2024 | 39332090 | PubTator, text mining | PubMed |
| HSV-1-induced N6-methyladenosine reprogramming via ICP0-mediated suppression of METTL14 potentiates oncolytic activity in glioma. | Cell Rep | 2024 | 39325621 | PubTator, text mining | PubMed |
| m6A mRNA methylation by METTL14 regulates early pancreatic cell differentiation. | EMBO J | 2024 | 39322760 | PubTator, text mining | PubMed |
| Propofol attenuates prostate cancer progression by upregulating TRHDE-AS1 expression, and METTL14 could mediate its m6A modification. | Clin Exp Pharmacol Physiol | 2024 | 39322401 | PubTator, text mining | PubMed |
| m6A RNA methylation controls salivary gland epithelial cell function and has a protective role in Sjögren's disease. | Ann Rheum Dis | 2024 | 39299724 | PubTator, text mining | PubMed |
| Correction: Dendrobine alleviates oleic acid-induced lipid accumulation by inhibiting FOS/METTL14 pathway. | J Mol Histol | 2024 | 39298064 | PubTator, text mining | PubMed |
| The role of RNA modifications in disease-associated macrophages. | Mol Ther Nucleic Acids | 2024 | 39296330 | PubTator, text mining | PubMed |
| Characterizing m6A modification factors and their interactions in colorectal cancer: implications for tumor subtypes and clinical outcomes. | Discov Oncol | 2024 | 39292326 | PubTator, text mining | PubMed |
| The m6A modification of ACSL4 mRNA sensitized esophageal squamous cell carcinoma to irradiation via accelerating ferroptosis. | Cell Biol Int | 2024 | 39285560 | PubTator, text mining | PubMed |
| METTL14-mediated HOXA5 m6A modification alleviates osteoporosis via promoting WNK1 transcription to suppress NLRP3-dependent macrophage pyroptosis. | J Orthop Translat | 2024 | 39280633 | PubTator, text mining | PubMed |
| Construction of a cuproptosis‑related lncRNA signature to predict biochemical recurrence of prostate cancer. | Oncol Lett | 2024 | 39268161 | PubTator, text mining | PubMed |
| m6A mRNA methylation in brown fat regulates systemic insulin sensitivity via an inter-organ prostaglandin signaling axis independent of UCP1. | Cell Metab | 2024 | 39255799 | PubTator, text mining | PubMed |
| Epitranscriptomics and epigenetics: two sides of the same coin? | Clin Epigenetics | 2024 | 39252109 | PubTator, text mining | PubMed |
| Increased m6A RNA methylation and METTL3 expression may contribute to the synovitis progression of rheumatoid arthritis. | Exp Cell Res | 2024 | 39245197 | PubTator, text mining | PubMed |
| Structures and mechanisms of the RNA m 6A writer. | Acta Biochim Biophys Sin (Shanghai) | 2024 | 39238441 | PubTator, text mining | PubMed |
| METTL14 inhibits Aβ1-42-induced neuronal injury through regulating the stability of CBLN4 mRNA in Alzheimer's disease. | J Bioenerg Biomembr | 2024 | 39235700 | PubTator, text mining | PubMed |
| METTL14-mediated lncRNA-FAS-AS1 promotes osteoarthritis progression by up-regulating ADAM8. | Int J Rheum Dis | 2024 | 39221886 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/57721/papers?page=23